OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
On the HCPLive vaccination page, resources on the topics of medical news and expert insight into preventive medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on immunization, and more.
April 11, 2022
The adverse event rate was 2.2% for patients with IBD following 1 dose of the vaccine.
April 05, 2022
There was an adequate response for pediatric patients on biologics to the H1N1 and H3N2 serotypes.
March 31, 2022
The guidelines replace risk-based reccomendations for adults between 19-59 years.
March 30, 2022
Males between 50-64 who have been vaccinated without erythema were at the highest risk of GBS.
March 29, 2022
Nearly all of the doctors polled recommended the pneumococcal vaccine for patients with cardiovascular disease aged 65 years and older.
March 12, 2022
As influenza A(H3N2) remains the most prevalent subtype in the US, investigators estimated the available flu shot is not significantly preventing positive cases.
February 21, 2022
An executive with Seqirus discusses the company's work to address age-related flu severity risks.
February 20, 2022
A look into the research and prospects Seqirus looks to fulfill with the technology platofrm.
February 17, 2022
A new study suggests even the phrasing of telemedicine notifications may make a difference in vaccine uptake.
February 15, 2022
An Israel cohort analysis suggests a "hybrid" of natural and vaccine-induced immunity is associated with the rare likelihood of SARS-CoV-2 reinfection.